{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:11:41Z","timestamp":1773763901714,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12868-014-0134-2","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T12:33:50Z","timestamp":1418992430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus"],"prefix":"10.1186","volume":"15","author":[{"given":"Germ\u00e1n","family":"Sierra-Paredes","sequence":"first","affiliation":[]},{"given":"Ana I","family":"Loureiro","sequence":"additional","affiliation":[]},{"given":"Lyndon C","family":"Wright","sequence":"additional","affiliation":[]},{"given":"Germ\u00e1n","family":"Sierra-Marcu\u00f1o","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcio","family":"Soares-da-Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,12,20]]},"reference":[{"key":"134_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1528-1167.2007.00984.x","volume":"48","author":"C Elger","year":"2007","unstructured":"Elger C, Bialer M, Cramer JA, Maia J, Almeida L, Soares-da-Silva P: Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Epilepsia. 2007, 48: 497-504. 10.1111\/j.1528-1167.2007.00984.x.","journal-title":"Epilepsia"},{"key":"134_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.eplepsyres.2010.01.014","volume":"89","author":"E Ben-Menachem","year":"2010","unstructured":"Ben-Menachem E, Gabbai AA, Hufnagel A, Maia J, Almeida L, Soares-da-Silva P: Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy. Epilepsy Res. 2010, 89: 278-285. 10.1016\/j.eplepsyres.2010.01.014.","journal-title":"Epilepsy Res"},{"key":"134_CR3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1528-1167.2008.01946.x","volume":"50","author":"C Elger","year":"2009","unstructured":"Elger C, Halasz P, Maia J, Almeida L, Soares-da-Silva P: Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia. 2009, 50: 454-463. 10.1111\/j.1528-1167.2008.01946.x.","journal-title":"Epilepsia"},{"key":"134_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1600-0404.2009.01218.x","volume":"120","author":"A Gil-Nagel","year":"2009","unstructured":"Gil-Nagel A, Lopes-Lima J, Almeida L, Maia J, Soares-da-Silva P: Efficacy and safety of 800 and 1200\u00a0mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Acta Neurol Scand. 2009, 120: 281-287. 10.1111\/j.1600-0404.2009.01218.x.","journal-title":"Acta Neurol Scand"},{"issue":"Suppl. 1","key":"134_CR5","first-page":"395","volume":"14","author":"M Sperling","year":"2014","unstructured":"Sperling M, Harvey J, Biraben A, Galimberti CA, Kowacs P, Hong SB, Cheng H, Blum D, Nunes T, Soares-da-Silva P: Adjunctive eslicarbazepine acetate in patients with refractory partial-onset seizures: Efficacy results of a 12\u00a0week randomized placebo-controlled study. Epilepsy Curr. 2014, 14 (Suppl. 1): 395-395.","journal-title":"Epilepsy Curr"},{"key":"134_CR6","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1111\/j.1528-1167.2010.02660.x","volume":"51","author":"P Halasz","year":"2010","unstructured":"Halasz P, Cramer JA, Hodoba D, Czlonkowska A, Guekht A, Maia J, Elger C, Almeida L, Soares-da-Silva P: Long-term efficacy and safety of eslicarbazepine acetate: Results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy. Epilepsia. 2010, 51: 1963-1969. 10.1111\/j.1528-1167.2010.02660.x.","journal-title":"Epilepsia"},{"key":"134_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.eplepsyres.2012.07.014","volume":"103","author":"A Hufnagel","year":"2013","unstructured":"Hufnagel A, Ben-Menachem E, Gabbai AA, Falcao A, Almeida L, Soares-da-Silva P: Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study. Epilepsy Res. 2013, 103: 262-269. 10.1016\/j.eplepsyres.2012.07.014.","journal-title":"Epilepsy Res"},{"issue":"suppl. 7","key":"134_CR8","first-page":"441","volume":"49","author":"J Lopes-Lima","year":"2008","unstructured":"Lopes-Lima J, Gil-Nagel A, Maia J, Almeida L, Soares-da-Silva P: Long-term treatment of partial epilepsy with eslicarbazepine acetate (ESL): results of a one-year open-label extension of study BIA-2093-303. Epilepsia. 2008, 49 (suppl. 7): 441-442.","journal-title":"Epilepsia"},{"key":"134_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/bdd.549","volume":"28","author":"A Falcao","year":"2007","unstructured":"Falcao A, Maia J, Almeida L, Mazur D, Gellert M, Soares-da-Silva P: Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2\u2013093), a new voltage-gated sodium channel blocker. Biopharm Drug Dispos. 2007, 28: 249-256. 10.1002\/bdd.549.","journal-title":"Biopharm Drug Dispos"},{"key":"134_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00228-007-0414-1","volume":"64","author":"L Almeida","year":"2008","unstructured":"Almeida L, Potgieter JH, Maia J, Potgieter MA, Mota F, Soares-da-Silva P: Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment. Eur J Clin Pharmacol. 2008, 64: 267-273. 10.1007\/s00228-007-0414-1.","journal-title":"Eur J Clin Pharmacol"},{"key":"134_CR11","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1177\/0091270008319706","volume":"48","author":"L Almeida","year":"2008","unstructured":"Almeida L, Minciu I, Nunes T, Butoianu N, Falcao A, Magureanu SA, Soares-da-Silva P: Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsy. J Clin Pharmacol. 2008, 48: 966-977. 10.1177\/0091270008319706.","journal-title":"J Clin Pharmacol"},{"key":"134_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5414\/CPP46119","volume":"46","author":"J Maia","year":"2008","unstructured":"Maia J, Almeida L, Falc\u00e3o A, Soares E, Mota F, Potgieter JH, Potgieter MA, Soares-da-Silva P: Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate. Int J Clin Pharmacol Ther. 2008, 46: 119-130. 10.5414\/CPP46119.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"134_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.eplepsyres.2011.05.013","volume":"96","author":"E Perucca","year":"2011","unstructured":"Perucca E, Elger C, Halasz P, Falcao A, Almeida L, Soares-da-Silva P: Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures. Epilepsy Res. 2011, 96: 132-139. 10.1016\/j.eplepsyres.2011.05.013.","journal-title":"Epilepsy Res"},{"issue":"Suppl. 6","key":"134_CR14","first-page":"118","volume":"52","author":"N Pires","year":"2011","unstructured":"Pires N, Palma N, Loureiro AI, Bonifacio MJ, Wright LC, Soares-da-Silva P: Effects of eslicarbazepine acetate, eslicarbazepine, carbamazepine and oxcarbazepine in the maximal electroconvulsive shock test in the mice. Epilepsia. 2011, 52 (Suppl. 6): 118.","journal-title":"Epilepsia"},{"issue":"Suppl. 6","key":"134_CR15","first-page":"119","volume":"52","author":"G Sierra-Paredes","year":"2011","unstructured":"Sierra-Paredes G, Sierra-Marcuno G, Loureiro AI, Wright LC, Soares-da-Silva P: Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus. Epilepsia. 2011, 52 (Suppl. 6): 119.","journal-title":"Epilepsia"},{"issue":"Suppl. 6","key":"134_CR16","first-page":"118","volume":"52","author":"L Torrao","year":"2011","unstructured":"Torrao L, Machado R, Pires N, Palma N, Bonifacio MJ, Wright LC, Soares-da-Silva P: Effects of eslicarbazepine acetate, eslicarbazepine, carbamazepine and oxcarbazepine in the 6-HZ psychomotor seizure model in the mice. Epilepsia. 2011, 52 (Suppl. 6): 118-119.","journal-title":"Epilepsia"},{"issue":"Suppl. 6","key":"134_CR17","first-page":"260","volume":"52","author":"K Brady","year":"2011","unstructured":"Brady K, Hebeisen S, Konrad D, Soares-da-Silva P: The effects of eslicarbazepine, R-licarbazepine, oxcarbazepine and carbamazepine on ion transmission Cav3.2 channels. Epilepsia. 2011, 52 (Suppl. 6): 260.","journal-title":"Epilepsia"},{"issue":"Suppl. 6","key":"134_CR18","first-page":"257","volume":"52","author":"S Hebeisen","year":"2011","unstructured":"Hebeisen S, Brady K, Konrad D, Soares-da-Silva P: Inhibitory effects of eslicarbazepine acetate and its metabolites against neuronal voltage-gated sodium channels. Epilepsia. 2011, 52 (Suppl. 6): 257-258.","journal-title":"Epilepsia"},{"key":"134_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neuropharm.2014.09.008","volume":"89","author":"S Hebeisen","year":"2015","unstructured":"Hebeisen S, Pires N, Loureiro AI, Bonifacio MJ, Palma N, Whyment A, Spanswick D, Soares-da-Silva P: Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide. Neuropharmacology. 2015, 89: 122-135. 10.1016\/j.neuropharm.2014.09.008.","journal-title":"Neuropharmacology"},{"key":"134_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cm.970130302","volume":"13","author":"I Spector","year":"1989","unstructured":"Spector I, Shochet NR, Blasberger D, Kashman Y: Latrunculins\u2013novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D. Cell Motil Cytoskeleton. 1989, 13: 127-144. 10.1002\/cm.970130302.","journal-title":"Cell Motil Cytoskeleton"},{"key":"134_CR21","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1523\/JNEUROSCI.18-07-02423.1998","volume":"18","author":"DW Allison","year":"1998","unstructured":"Allison DW, Gelfand VI, Spector I, Craig AM: Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons: differential attachment of NMDA versus AMPA receptors. J Neurosci. 1998, 18: 2423-2436.","journal-title":"J Neurosci"},{"key":"134_CR22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1523\/JNEUROSCI.20-01-00022.2000","volume":"20","author":"R Sattler","year":"2000","unstructured":"Sattler R, Xiong Z, Lu WY, MacDonald JF, Tymianski M: Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity. J Neurosci. 2000, 20: 22-33.","journal-title":"J Neurosci"},{"key":"134_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0896-6273(00)00064-7","volume":"27","author":"M Morales","year":"2000","unstructured":"Morales M, Colicos MA, Goda Y: Actin-dependent regulation of neurotransmitter release at central synapses. Neuron. 2000, 27: 539-550. 10.1016\/S0896-6273(00)00064-7.","journal-title":"Neuron"},{"key":"134_CR24","first-page":"19","volume":"142","author":"WE Houssen","year":"2006","unstructured":"Houssen WE, Jaspars M, Wease KN, Scott RH: Acute actions of marine toxin latrunculin A on the electrophysiological properties of cultured dorsal root ganglion neurones. Comp Biochem Physiol. 2006, 142: 19-29.","journal-title":"Comp Biochem Physiol"},{"key":"134_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.eplepsyres.2007.08.006","volume":"77","author":"G Sierra-Paredes","year":"2007","unstructured":"Sierra-Paredes G, Oreiro-Garcia MT, Vazquez-Illanes MD, Sierra-Marcuno G: Effect of eslicarbazepine acetate (BIA 2\u2013093) on latrunculin A-induced seizures and extracellular amino acid concentrations in the rat hippocampus. Epilepsy Res. 2007, 77: 36-43. 10.1016\/j.eplepsyres.2007.08.006.","journal-title":"Epilepsy Res"},{"key":"134_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1385\/JMN:28:2:151","volume":"28","author":"G Sierra-Paredes","year":"2006","unstructured":"Sierra-Paredes G, Oreiro-Garcia T, Nunez-Rodriguez A, Vazquez-Lopez A, Sierra-Marcuno G: Seizures induced by in vivo latrunculin a and jasplakinolide microperfusion in the rat hippocampus. J Mol Neurosci. 2006, 28: 151-160. 10.1385\/JMN:28:2:151.","journal-title":"J Mol Neurosci"},{"key":"134_CR27","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/j.1528-1167.2012.03519.x","volume":"53","author":"M Bialer","year":"2012","unstructured":"Bialer M, Soares-da-Silva P: Pharmacokinetics and drug interactions of eslicarbazepine acetate. Epilepsia. 2012, 53: 935-946. 10.1111\/j.1528-1167.2012.03519.x.","journal-title":"Epilepsia"},{"key":"134_CR28","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1528-1157.1984.tb03462.x","volume":"25","author":"DW Bonhaus","year":"1984","unstructured":"Bonhaus DW, Lippincott SE, Huxtable RJ: Subcellular distribution of neuroactive amino acids in brains of genetically epileptic rats. Epilepsia. 1984, 25: 564-568. 10.1111\/j.1528-1157.1984.tb03462.x.","journal-title":"Epilepsia"},{"key":"134_CR29","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/BF00964820","volume":"14","author":"TR Guilarte","year":"1989","unstructured":"Guilarte TR: Regional changes in the concentrations of glutamate, glycine, taurine, and GABA in the vitamin B-6 deficient developing rat brain: association with neonatal seizures. Neurochem Res. 1989, 14: 889-897. 10.1007\/BF00964820.","journal-title":"Neurochem Res"},{"key":"134_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0006-8993(94)91237-8","volume":"637","author":"P Nilsson","year":"1994","unstructured":"Nilsson P, Ronne-Engstrom E, Flink R, Ungerstedt U, Carlson H, Hillered L: Epileptic seizure activity in the acute phase following cortical impact trauma in rat. Brain Res. 1994, 637: 227-232. 10.1016\/0006-8993(94)91237-8.","journal-title":"Brain Res"},{"key":"134_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0304-3940(98)00332-2","volume":"248","author":"G Sierra-Paredes","year":"1998","unstructured":"Sierra-Paredes G, Galan-Valiente J, Vazquez-Illanes MD, Aguilar-Veiga E, Soto-Otero R, Mendez-Alvarez E, Sierra-Marcuno G: Extracellular amino acids in the rat hippocampus during picrotoxin threshold seizures in chronic microdialysis experiments. Neurosci Lett. 1998, 248: 53-56. 10.1016\/S0304-3940(98)00332-2.","journal-title":"Neurosci Lett"},{"key":"134_CR32","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1023\/A:1022528522373","volume":"24","author":"DM Labiner","year":"1999","unstructured":"Labiner DM, Yan CC, Weinand ME, Huxtable RJ: Disturbances of amino acids from temporal lobe synaptosomes in human complex partial epilepsy. Neurochem Res. 1999, 24: 1379-1383. 10.1023\/A:1022528522373.","journal-title":"Neurochem Res"},{"key":"134_CR33","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1023\/A:1022580506443","volume":"24","author":"AL Sherwin","year":"1999","unstructured":"Sherwin AL: Neuroactive amino acids in focally epileptic human brain: a review. Neurochem Res. 1999, 24: 1387-1395. 10.1023\/A:1022580506443.","journal-title":"Neurochem Res"},{"key":"134_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0920-1211(03)00035-4","volume":"54","author":"PM Thomas","year":"2003","unstructured":"Thomas PM, Phillips JP, Delanty N, O\u2019Connor WT: Elevated extracellular levels of glutamate, aspartate and gamma-aminobutyric acid within the intraoperative, spontaneously epileptiform human hippocampus. Epilepsy Res. 2003, 54: 73-79. 10.1016\/S0920-1211(03)00035-4.","journal-title":"Epilepsy Res"},{"key":"134_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.surneu.2004.02.031","volume":"63","author":"PM Thomas","year":"2005","unstructured":"Thomas PM, Phillips JP, O\u2019Connor WT: Microdialysis of the lateral and medial temporal lobe during temporal lobe epilepsy surgery. Surg Neurol. 2005, 63: 70-79. 10.1016\/j.surneu.2004.02.031.","journal-title":"Surg Neurol"},{"key":"134_CR36","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1471-4159.2010.07048.x","volume":"115","author":"T Melo","year":"2010","unstructured":"Melo T, Bigini P, Sonnewald U, Balosso S, Cagnotto A, Barbera S, Uboldi S, Vezzani A, Mennini T: Neuronal hyperexcitability and seizures are associated with changes in glial-neuronal interactions in the hippocampus of a mouse model of epilepsy with mental retardation. J Neurochem. 2010, 115: 1445-1454. 10.1111\/j.1471-4159.2010.07048.x.","journal-title":"J Neurochem"},{"key":"134_CR37","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0301-0082(95)00030-5","volume":"47","author":"HF Bradford","year":"1995","unstructured":"Bradford HF: Glutamate, GABA and epilepsy. Prog Neurobiol. 1995, 47: 477-511. 10.1016\/0301-0082(95)00030-5.","journal-title":"Prog Neurobiol"},{"key":"134_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.eplepsyres.2013.08.007","volume":"107","author":"K Kanamori","year":"2013","unstructured":"Kanamori K, Ross BD: Electrographic seizures are significantly reduced by in vivo inhibition of neuronal uptake of extracellular glutamine in rat hippocampus. Epilepsy Res. 2013, 107: 20-36. 10.1016\/j.eplepsyres.2013.08.007.","journal-title":"Epilepsy Res"},{"key":"134_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.expneurol.2014.04.014","volume":"257C","author":"M Soukupova","year":"2014","unstructured":"Soukupova M, Binaschi A, Falcicchia C, Zucchini S, Roncon P, Palma E, Magri E, Grandi E, Simonato M: Impairment of GABA release in the hippocampus at the time of the first spontaneous seizure in the pilocarpine model of temporal lobe epilepsy. Exp Neurol. 2014, 257C: 39-49. 10.1016\/j.expneurol.2014.04.014.","journal-title":"Exp Neurol"},{"key":"134_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0920-1211(01)00231-5","volume":"44","author":"D Hainzl","year":"2001","unstructured":"Hainzl D, Parada A, Soares-da-Silva P: Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(\u2212)-10,11-dihydro-10-hydroxy carbamazepine. Epilepsy Res. 2001, 44: 197-206. 10.1016\/S0920-1211(01)00231-5.","journal-title":"Epilepsy Res"},{"key":"134_CR41","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1472-8206.2008.00617.x","volume":"22","author":"G Alves","year":"2008","unstructured":"Alves G, Figueiredo I, Castel-Branco M, Lourenco N, Falcao A, Caramona M, Soares-da-Silva P: Disposition of eslicarbazepine acetate in the mouse after oral administration. Fund Clin Pharmacol. 2008, 22: 529-536. 10.1111\/j.1472-8206.2008.00617.x.","journal-title":"Fund Clin Pharmacol"},{"key":"134_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.eplepsyres.2013.11.017","volume":"108","author":"H Potschka","year":"2014","unstructured":"Potschka H, Soerensen J, Pekcec A, Loureiro A, Soares-da-Silva P: Effect of eslicarbazepine acetate in the corneal kindling progression and the amygdala kindling model of temporal lobe epilepsy. Epilepsy Res. 2014, 108: 212-222. 10.1016\/j.eplepsyres.2013.11.017.","journal-title":"Epilepsy Res"},{"key":"134_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0079-6123(08)60449-5","volume":"116","author":"AG Chapman","year":"1998","unstructured":"Chapman AG: Glutamate receptors in epilepsy. Prog Brain Res. 1998, 116: 371-383. 10.1016\/S0079-6123(08)60449-5.","journal-title":"Prog Brain Res"},{"key":"134_CR44","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2174\/187152707781387251","volume":"6","author":"G Sierra-Paredes","year":"2007","unstructured":"Sierra-Paredes G, Sierra-Marcuno G: Extrasynaptic GABA and glutamate receptors in epilepsy. CNS Neurol Disord Drug Targets. 2007, 6: 288-300. 10.2174\/187152707781387251.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"134_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0014-2999(96)00830-8","volume":"319","author":"I Smolders","year":"1997","unstructured":"Smolders I, Van Belle K, Ebinger G, Michotte Y: Hippocampal and cerebellar extracellular amino acids during pilocarpine-induced seizures in freely moving rats. Eur J Pharmacol. 1997, 319: 21-29. 10.1016\/S0014-2999(96)00830-8.","journal-title":"Eur J Pharmacol"},{"key":"134_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neulet.2005.06.063","volume":"388","author":"A Vazquez-Lopez","year":"2005","unstructured":"Vazquez-Lopez A, Sierra-Paredes G, Sierra-Marcuno G: Seizures induced by microperfusion of glutamate and glycine in the hippocampus of rats pretreated with latrunculin A. Neurosci Lett. 2005, 388: 81-85. 10.1016\/j.neulet.2005.06.063.","journal-title":"Neurosci Lett"},{"key":"134_CR47","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1073\/pnas.0606451104","volume":"104","author":"JJ Laschet","year":"2007","unstructured":"Laschet JJ, Kurcewicz I, Minier F, Trottier S, Khallou-Laschet J, Louvel J, Gigout S, Turak B, Biraben A, Scarabin JM, Devaux B, Chauvel P, Pumain R: Dysfunction of GABAA receptor glycolysis-dependent modulation in human partial epilepsy. Proc Natl Acad Sci U S A. 2007, 104: 3472-3477. 10.1073\/pnas.0606451104.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"134_CR48","doi-asserted-by":"publisher","first-page":"15073","DOI":"10.1073\/pnas.1313505110","volume":"110","author":"T Dugladze","year":"2013","unstructured":"Dugladze T, Maziashvili N, Borgers C, Gurgenidze S, Haussler U, Winkelmann A, Haas CA, Meier JC, Vida I, Kopell NJ, Gloveli T: GABA(B) autoreceptor-mediated cell type-specific reduction of inhibition in epileptic mice. Proc Natl Acad Sci U S A. 2013, 110: 15073-15078. 10.1073\/pnas.1313505110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"134_CR49","doi-asserted-by":"publisher","first-page":"8229","DOI":"10.1523\/JNEUROSCI.1469-05.2005","volume":"25","author":"J Epsztein","year":"2005","unstructured":"Epsztein J, Represa A, Jorquera I, Ben-Ari Y, Crepel V: Recurrent mossy fibers establish aberrant kainate receptor-operated synapses on granule cells from epileptic rats. J Neurosci. 2005, 25: 8229-8239. 10.1523\/JNEUROSCI.1469-05.2005.","journal-title":"J Neurosci"},{"key":"134_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0306-4522(00)00359-6","volume":"101","author":"F Suzuki","year":"2000","unstructured":"Suzuki F, Hirai H, Onteniente B, Riban V, Matsuda M, Kurokawa K: Long-term increase of GluR2 alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor subunit in the dispersed dentate gyrus after intrahippocampal kainate injection in the mouse. Neuroscience. 2000, 101: 41-50. 10.1016\/S0306-4522(00)00359-6.","journal-title":"Neuroscience"},{"key":"134_CR51","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/1098-1063(2000)10:3<305::AID-HIPO11>3.0.CO;2-I","volume":"10","author":"V Bouilleret","year":"2000","unstructured":"Bouilleret V, Loup F, Kiener T, Marescaux C, Fritschy JM: Early loss of interneurons and delayed subunit-specific changes in GABA(A)-receptor expression in a mouse model of mesial temporal lobe epilepsy. Hippocampus. 2000, 10: 305-324. 10.1002\/1098-1063(2000)10:3<305::AID-HIPO11>3.0.CO;2-I.","journal-title":"Hippocampus"},{"key":"134_CR52","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1126\/science.1097065","volume":"305","author":"C Bernard","year":"2004","unstructured":"Bernard C, Anderson A, Becker A, Poolos NP, Beck H, Johnston D: Acquired dendritic channelopathy in temporal lobe epilepsy. Science. 2004, 305: 532-535. 10.1126\/science.1097065.","journal-title":"Science"},{"key":"134_CR53","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nn1260","volume":"7","author":"H Misonou","year":"2004","unstructured":"Misonou H, Mohapatra DP, Park EW, Leung V, Zhen D, Misonou K, Anderson AE, Trimmer JS: Regulation of ion channel localization and phosphorylation by neuronal activity. Nat Neurosci. 2004, 7: 711-718. 10.1038\/nn1260.","journal-title":"Nat Neurosci"},{"key":"134_CR54","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1523\/JNEUROSCI.22-09-03645.2002","volume":"22","author":"H Su","year":"2002","unstructured":"Su H, Sochivko D, Becker A, Chen J, Jiang Y, Yaari Y, Beck H: Upregulation of a T-type Ca2+ channel causes a long-lasting modification of neuronal firing mode after status epilepticus. J Neurosci. 2002, 22: 3645-3655.","journal-title":"J Neurosci"},{"key":"134_CR55","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3109\/00498258609043567","volume":"16","author":"H Schutz","year":"1986","unstructured":"Schutz H, Feldmann KF, Faigle JW, Kriemler HP, Winkler T: The metabolism of 14C-oxcarbazepine in man. Xenobiotica. 1986, 16: 769-778. 10.3109\/00498258609043567.","journal-title":"Xenobiotica"},{"key":"134_CR56","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/cp.1999.v66.103170001","volume":"66","author":"A Volosov","year":"1999","unstructured":"Volosov A, Xiaodong S, Perucca E, Yagen B, Sintov A, Bialer M: Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects. Clin Pharmacol Ther. 1999, 66: 547-553. 10.1016\/S0009-9236(99)90061-9.","journal-title":"Clin Pharmacol Ther"},{"key":"134_CR57","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1528-1167.2010.02751.x","volume":"52","author":"P Soares-da-Silva","year":"2011","unstructured":"Soares-da-Silva P, Bulling A, Hebeisen S, Konrad D: The effects of eslicarbazepine, R-licarbazepine and carbamazepine on ion transmission through Kv7.2 channels. Epilepsia. 2011, 52: 258-259.","journal-title":"Epilepsia"},{"key":"134_CR58","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/j.1476-5381.2009.00111.x","volume":"156","author":"DA Brown","year":"2009","unstructured":"Brown DA, Passmore GM: Neural KCNQ (Kv7) channels. Br J Pharmacol. 2009, 156: 1185-1195. 10.1111\/j.1476-5381.2009.00111.x.","journal-title":"Br J Pharmacol"},{"key":"134_CR59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nn1375","volume":"8","author":"HC Peters","year":"2005","unstructured":"Peters HC, Hu H, Pongs O, Storm JF, Isbrandt D: Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat Neurosci. 2005, 8: 51-60. 10.1038\/nn1375.","journal-title":"Nat Neurosci"},{"issue":"Suppl 2","key":"134_CR60","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1528-1167.2008.02007.x","volume":"50","author":"A Pitkanen","year":"2009","unstructured":"Pitkanen A, Immonen RJ, Grohn OH, Kharatishvili I: From traumatic brain injury to posttraumatic epilepsy: what animal models tell us about the process and treatment options. Epilepsia. 2009, 50 (Suppl 2): 21-29. 10.1111\/j.1528-1167.2008.02007.x.","journal-title":"Epilepsia"},{"key":"134_CR61","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0022-3565(25)05100-6","volume":"106","author":"EA Swinyard","year":"1952","unstructured":"Swinyard EA, Brown WC, Goodman LS: Comparative assays of antiepileptic drugs in mice and rats. J Pharmacol Exp Ther. 1952, 106: 319-330.","journal-title":"J Pharmacol Exp Ther"},{"key":"134_CR62","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0021-9673(98)00836-X","volume":"828","author":"H Liu","year":"1998","unstructured":"Liu H, Sa\u00f1uda-Pe\u00f1a C, Harvey-White JD, Kalra S, Cohen SA: Determination of submicromolar concentrations of neurotransmitter amino acids by fluorescence detection using a modification of the 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate method for amino acid analysis. J Chromatography A. 1998, 828: 383-395. 10.1016\/S0021-9673(98)00836-X.","journal-title":"J Chromatography A"},{"key":"134_CR63","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/bmc.499","volume":"19","author":"MT Oreiro-Garcia","year":"2005","unstructured":"Oreiro-Garcia MT, Vazquez-Illanes MD, Sierra-Paredes G, Sierra-Marcuno G: Analysis of neuroactive amino acids from microdialysate samples by fluorescence detection using a modification of the 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate method. Biomed Chromatogr. 2005, 19: 720-724. 10.1002\/bmc.499.","journal-title":"Biomed Chromatogr"},{"key":"134_CR64","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1124\/dmd.111.038620","volume":"39","author":"AI Loureiro","year":"2005","unstructured":"Loureiro AI, Fernandes-Lopes C, Bonifacio MJ, Wright LC, Soares-da-Silva P: Hepatic UDP-glucuronosyltransferase is responsible for eslicarbazepine glucuronidation. Drug Metab Dispos. 2005, 39: 1486-1494. 10.1124\/dmd.111.038620.","journal-title":"Drug Metab Dispos"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12868-014-0134-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-014-0134-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-014-0134-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-014-0134-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T14:39:26Z","timestamp":1747233566000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/s12868-014-0134-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["134"],"URL":"https:\/\/doi.org\/10.1186\/s12868-014-0134-2","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"3 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"134"}}